Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

NCT00281840 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: docetaxel
PROCEDURE: conventional surgery
RADIATION: radiation therapy

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]